AstraZeneca PLC (AZN) Cash Flow Statement
AstraZeneca PLC (AZN) generated $13.7B of operating cash flow over the twelve months to 2026-06-30, spent $1.9B on capital expenditure and had free cash flow of $11.8B, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AZNAstraZeneca PLCFollow AZN — free
—
Price chart with a free account
- Market cap
- 274.1B
- P/E TTM
- 25.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 30 Oct, in 6 days
| Line | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.58 | 2.62 | 2.97 | 4.80 | 5.96 | 9.81 | 10.35 | 11.86 | 14.58 | 13.70 | |
| Capital expenditure | 1.33 | 1.04 | 0.98 | 0.96 | 1.09 | 1.09 | 1.36 | 1.92 | 2.81 | -1.94 | |
| Free cash flow | 2.25 | 1.58 | 1.99 | 3.84 | 4.87 | 8.72 | 8.98 | 9.94 | 11.77 | 11.77 | |
| Dividends paid | — | — | — | — | — | — | 4.48 | 4.63 | 4.97 | — |
USD billions · SEC XBRL
AstraZeneca PLC — questions
- What is AstraZeneca PLC's operating cash flow?
- $13.7B over the twelve months to 2026-06-30.
- How much does AstraZeneca PLC spend on capital expenditure?
- $1.9B over the twelve months to 2026-06-30.
- What is AstraZeneca PLC's free cash flow?
- $11.8B over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from AstraZeneca PLC's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.